Immunization Newsbriefs (c) Copyright
Information Inc., Bethesda, MD. Brought to you by the National Network for
Immunization Information (NNii). Visit NNii's new website at
http://www.immunizationinfo.org.
------------------------------------------------------------
March 25, 2002
INTERNATIONAL IMMUNIZATION NEWS
"Study: 3 Mil. Susceptible to Measles"
Tokyo Daily Yomiuri (www.yomiuri.co.jp/index-e.htm)
(03/23/02) P. 2
In Japan, a recent study by Nobuhiko Okabe,
director of the Infectious Disease Surveillance Center (IDSC) of the National
Institute of Infectious Diseases, and a senior researcher at the IDSC have found
that over 3 million people in Japan
could be susceptible to measles. While half of all children under 12 months and
80 percent to 90 percent of children over two years of age have been vaccinated
against the disease, about 3 million people from all age groups are still
susceptible to measles. The researchers say that young people in their 20s need
to be particularly careful, because there is a greater likelihood of adults and
babies developing complications, such as pneumonia, if they come down with
measles. Some 230,000 people in Japan
developed measles last year, and approximately 50 people die from the disease
each year. In the past, Japanese parents were obliged by law to have their
children vaccinated against measles, but that law was relaxed in 1994. However,
there are growing reports of Japanese tourists entering foreign countries with
the disease, posing a major threat of infection to other people. In Europe, a
number of countries have been highly critical of Japan's vaccination policy, and
they are expected to ask the Japanese government to raise its vaccination rate.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.